Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 73 (2023): Issue 2 (June 2023)
Open Access
Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development
Jurica Baranasic
Jurica Baranasic
,
Yasmeen Niazi
Yasmeen Niazi
,
Subhayan Chattopadhyay
Subhayan Chattopadhyay
,
Lada Rumora
Lada Rumora
,
Lorna Ćorak
Lorna Ćorak
,
Andrea Vukić Dugac
Andrea Vukić Dugac
,
Marko Jakopović
Marko Jakopović
,
Miroslav Samaržija
Miroslav Samaržija
,
Asta Försti
Asta Försti
and
Jelena Knežević
Jelena Knežević
| Jun 12, 2023
Acta Pharmaceutica
Volume 73 (2023): Issue 2 (June 2023)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jun 12, 2023
Page range:
243 - 256
Accepted:
Jan 09, 2023
DOI:
https://doi.org/10.2478/acph-2023-0019
Keywords
GWAS
,
SNP
,
COPD
,
lung cancer
,
immune-related genes
,
NF-κB
© 2023 Jurica Baranasic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.